Unique, Chemistry-Driven Approach
Developing novel Microbiome Metabolic Therapies (MMT™) to drive functional outputs of the microbiome
Kaleido Biosciences is a clinical-stage healthcare company with a chemistry-driven approach to targeting the microbiome to treat disease and improve human health.
